Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$151.97 /

+2.73 (+1.83%)

07:02
09/10/20
09/10
07:02
09/10/20
07:02

Eli Lilly to present new data from cancer research pipeline at ESMO

Data from 20 studies across Eli Lilly's oncology product portfolio will be presented at the European Society for Medical Oncology, or ESMO, virtual congress, September 19-21. The data include results from the Phase 3 monarchE study of Verzenio in combination with standard adjuvant endocrine therapy, or ET, for the treatment of high risk HR+, HER2- early breast cancer. Lilly continues to investigate Verzenio across the breast cancer continuum, which has now shown results in people with high risk HR+, HER2- early breast cancer. At ESMO, Lilly will share detailed results from the Phase 3 monarchE study, which demonstrated Verzenio plus standard adjuvant ET significantly decreased the risk of breast cancer recurrence compared to standard adjuvant ET alone in people with high risk HR+, HER2- early breast cancer. These results make Verzenio the only CDK4 & 6 inhibitor to demonstrate statistically significant improvement in invasive disease-free survival in this setting. Lilly also will present findings on genomic testing, biomarkers and treatment patterns in early breast cancer as well as the use of Ki-67 testing and scoring in HR+, HER2- early breast cancer - a biomarker of particular interest in the study of high risk early breast cancer. Additional Verzenio data to be presented include a final overall survival analysis of Verzenio monotherapy in patients with HR+, HER2- advanced breast cancer in the nextMONARCH trial. The approval of Retevmo - a selective RET kinase inhibitor - marked the most rapid timeline in the development of an oncology medicine with multiple indications, and was based on results from the Phase 1/2 LIBRETTO-001 trial, the largest clinical trial in patients with RET-altered cancers. During ESMO, Lilly will present patient-reported outcomes and quality of life findings from both the RET fusion-positive NSCLC and RET-mutant MTC patient cohorts. Lilly will also present new safety data on patients with previously treated metastatic RET fusion-positive NSCLC, including safety and efficacy outcomes assessed by category of last systemic therapy received prior to LIBRETTO-001 enrollment. An additional safety analysis, focusing on hypersensitivity reactions in RET fusion-positive NSCLC patients previously treated with immune checkpoint inhibitors, will also be presented. Details on the study design of two confirmatory Phase 3 trials, LIBRETTO-431 and LIBRETTO-531, will additionally be shared. Both Phase 3 trials are currently enrolling patients. Earlier this year, the FDA approved CYRAMZA in combination with erlotinib for the first-line treatment of people with metastatic NSCLC with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) mutations, based on results from the Phase 3 RELAY study. With this approval, CYRAMZA has now received six FDA approvals to treat certain types of lung, liver, stomach and colorectal cancers. CYRAMZA was also approved in the European Union earlier this year based on the RELAY results. During ESMO, Lilly will feature data from the RELAY trial looking at outcomes by EGFR mutation type in previously untreated EGFR-mutated metastatic NSCLC patients. Additionally, a systematic literature review will spotlight outcomes of treated patients with EGFR-mutated NSCLC harboring exon 19 deletions or exon 21 mutations.

  • 14

    Sep

  • 27

    Oct

LLY Eli Lilly
$151.97 /

+2.73 (+1.83%)

09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
09/03/20
Fly Intel: Top five analyst upgrades
09/03/20 Morgan Stanley
Morgan Stanley upgrades Eli Lilly on diabetes, Alzheimer's opportunities
09/03/20 Morgan Stanley
Eli Lilly upgraded to Overweight from Equal Weight at Morgan Stanley

TODAY'S FREE FLY STORIES

Downgrade
G4S downgraded to Sector Perform from Outperform at RBC Capital » 12:26
12/03/20
12/03
12:26
12/03/20
12:26
GFSZY

G4S

$0.00 /

+ (+0.00%)

RBC Capital analyst Andy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GFSZY G4S
$0.00 /

+ (+0.00%)

GFSZY G4S
$0.00 /

+ (+0.00%)

12:11 Today Deutsche Bank
G4S price target raised to 235 GBp from 210 GBp at Deutsche Bank
11/17/20 Deutsche Bank
G4S price target raised to 210 GBp from 170 GBp at Deutsche Bank
10/08/20 Kepler Cheuvreux
G4S downgraded to Hold from Buy at Kepler Cheuvreux
10/08/20 Kepler Cheuvreux
G4S downgraded to Hold from Buy at Kepler Cheuvreux
Conference/Events
Steven Madden management to meet virtually with B.Riley Securities » 12:25
12/03/20
12/03
12:25
12/03/20
12:25
SHOO

Steven Madden

$32.78 /

+0.52 (+1.61%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHOO Steven Madden
$32.78 /

+0.52 (+1.61%)

SHOO Steven Madden
$32.78 /

+0.52 (+1.61%)

11/12/20
Fly Intel: Top five analyst upgrades
11/12/20 KeyBanc
Steven Madden upgraded to Overweight from Sector Weight at KeyBanc
10/28/20 Loop Capital
Steven Madden price target raised to $25 from $22 at Loop Capital
10/28/20 Susquehanna
Steven Madden price target raised to $30 from $25 at Susquehanna
SHOO Steven Madden
$32.78 /

+0.52 (+1.61%)

Conference/Events
ChannelAdvisor management to meet virtually with B.Riley Securities » 12:25
12/03/20
12/03
12:25
12/03/20
12:25
ECOM

ChannelAdvisor

$14.94 /

+0.42 (+2.89%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ECOM ChannelAdvisor
$14.94 /

+0.42 (+2.89%)

ECOM ChannelAdvisor
$14.94 /

+0.42 (+2.89%)

11/05/20 Baird
ChannelAdvisor price target lowered to $18 from $20 at Baird
10/16/20
Fly Intel: Top five analyst upgrades
10/16/20 William Blair
William Blair upgrades ChannelAdvisor on shift to online retail spending
10/16/20 William Blair
ChannelAdvisor upgraded to Outperform from Market Perform at William Blair
ECOM ChannelAdvisor
$14.94 /

+0.42 (+2.89%)

General news
Oil Action: WTI crude » 12:25
12/03/20
12/03
12:25
12/03/20
12:25

Oil Action: WTI crude…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Options
Southwest call volume above normal and directionally bullish » 12:25
12/03/20
12/03
12:25
12/03/20
12:25
LUV

Southwest

$49.30 /

+1.86 (+3.92%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
LUV Southwest
$49.30 /

+1.86 (+3.92%)

LUV Southwest
$49.30 /

+1.86 (+3.92%)

11/30/20
Fly Intel: Top five analyst downgrades
11/30/20 Raymond James
Southwest downgraded to Outperform from Strong Buy at Raymond James
11/17/20 Jefferies
Southwest initiated with a Buy at Jefferies
11/12/20 Exane BNP Paribas
Southwest initiated with an Outperform at Exane BNP Paribas
LUV Southwest
$49.30 /

+1.86 (+3.92%)

  • 29
    Apr
LUV Southwest
$49.30 /

+1.86 (+3.92%)

LUV Southwest
$49.30 /

+1.86 (+3.92%)

LUV Southwest
$49.30 /

+1.86 (+3.92%)

Conference/Events
Jefferies commercial real estate analysts hold analyst/industry conference call » 12:25
12/03/20
12/03
12:25
12/03/20
12:25
TCO

Taubman Centers

$42.88 /

+0.04 (+0.09%)

, SPG

Simon Property

$90.25 /

+3.02 (+3.46%)

Commercial Real Estate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCO Taubman Centers
$42.88 /

+0.04 (+0.09%)

SPG Simon Property
$90.25 /

+3.02 (+3.46%)

TCO Taubman Centers
$42.88 /

+0.04 (+0.09%)

12/01/20 Compass Point
Compass Point upgrades Washington Prime to Buy amid bankruptcy fears
11/17/20 Compass Point
Macerich upgraded to Buy following peer's revised deal at Compass Point
11/16/20 Mizuho
Simon Property price target raised to $74 from $66 at Mizuho
11/16/20 Piper Sandler
Taubman Centers upgraded to Neutral from Underweight at Piper Sandler
SPG Simon Property
$90.25 /

+3.02 (+3.46%)

12/02/20 Argus
Simon Property downgraded to Hold from Buy at Argus
12/02/20 Argus
Simon Property downgraded to Hold from Buy at Argus
11/17/20 Compass Point
Macerich upgraded to Buy following peer's revised deal at Compass Point
11/16/20 Mizuho
Simon Property price target raised to $74 from $66 at Mizuho
TCO Taubman Centers
$42.88 /

+0.04 (+0.09%)

SPG Simon Property
$90.25 /

+3.02 (+3.46%)

  • 19
    Nov
SPG Simon Property
$90.25 /

+3.02 (+3.46%)

TCO Taubman Centers
$42.88 /

+0.04 (+0.09%)

SPG Simon Property
$90.25 /

+3.02 (+3.46%)

TCO Taubman Centers
$42.88 /

+0.04 (+0.09%)

SPG Simon Property
$90.25 /

+3.02 (+3.46%)

Conference/Events
Sage Therapeutics participates in a conference call with JPMorgan » 12:25
12/03/20
12/03
12:25
12/03/20
12:25
SAGE

Sage Therapeutics

$68.50 /

-0.14 (-0.20%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
SAGE Sage Therapeutics
$68.50 /

-0.14 (-0.20%)

SAGE Sage Therapeutics
$68.50 /

-0.14 (-0.20%)

12/01/20
Fly Intel: Top five analyst downgrades
12/01/20 Truist
Sage Therapeutics price target raised to $70 from $60 at Truist
12/01/20 Raymond James
Sage Therapeutics downgraded to Market Perform from Outperform at Raymond James
12/01/20 Citi
Sage Therapeutics price target lowered to $93 from $100 at Citi
SAGE Sage Therapeutics
$68.50 /

-0.14 (-0.20%)

SAGE Sage Therapeutics
$68.50 /

-0.14 (-0.20%)

Earnings
Methode Electronics 'confident' in $300M fiscal 2025 EBITDA target » 12:23
12/03/20
12/03
12:23
12/03/20
12:23
MEI

Methode Electronics

$36.11 /

+0.37 (+1.04%)

Methode Electronics said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEI Methode Electronics
$36.11 /

+0.37 (+1.04%)

MEI Methode Electronics
$36.11 /

+0.37 (+1.04%)

10/19/20 Baird
Methode Electronics reinstated with a Neutral at Baird
09/24/20 Craig-Hallum
Methode Electronics shares still 'meaningfully undervalued,' says Craig-Hallum
04/21/20 Craig-Hallum
Methode Electronics price target lowered to $35 from $40 at Craig-Hallum
03/19/20 B. Riley FBR
B. Riley FBR downgrades four names with exposure to auto manufacturers
MEI Methode Electronics
$36.11 /

+0.37 (+1.04%)

MEI Methode Electronics
$36.11 /

+0.37 (+1.04%)

Recommendations
Aveva price target lowered to 3,500 GBp from 3,574 GBp at UBS » 12:23
12/03/20
12/03
12:23
12/03/20
12:23
AVEVF

Aveva

$0.00 /

+ (+0.00%)

UBS analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVEVF Aveva
$0.00 /

+ (+0.00%)

AVEVF Aveva
$0.00 /

+ (+0.00%)

11/11/20 UBS
Aveva price target lowered to 4,455 GBp from 4,700 GBp at UBS
11/10/20 Credit Suisse
Aveva price target raised to 4,690 GBp from 4,400 GBp at Credit Suisse
11/06/20 Credit Suisse
Aveva price target lowered to 4,400 GBp from 4,800 GBp at Credit Suisse
11/06/20 Panmure Gordon
Aveva upgraded to Buy from Hold at Panmure Gordon
Recommendations
Deutsche Boerse price target raised to EUR 170 from EUR 165 at UBS » 12:23
12/03/20
12/03
12:23
12/03/20
12:23
DBOEY

Deutsche Boerse

$0.00 /

+ (+0.00%)

UBS analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DBOEY Deutsche Boerse
$0.00 /

+ (+0.00%)

DBOEY Deutsche Boerse
$0.00 /

+ (+0.00%)

11/25/20 UBS
Deutsche Boerse price target raised to EUR 165 from EUR 160 at UBS
11/24/20 Oddo BHF
Deutsche Boerse upgraded to Buy from Neutral at Oddo BHF
11/19/20 Barclays
Deutsche Boerse price target raised to EUR 150 from EUR 142 at Barclays
10/30/20 Barclays
Deutsche Boerse price target lowered to EUR 142 from EUR 150 at Barclays
On The Fly
Fly Intel: Wall Street's top stories at midday » 12:21
12/03/20
12/03
12:21
12/03/20
12:21
BA

Boeing

$240.75 /

+16.95 (+7.57%)

, CDXS

Codexis

$17.17 /

-1.74 (-9.20%)

, TSLA

Tesla

$592.59 /

+23.905 (+4.20%)

, ZS

Zscaler

$184.88 /

+37.92 (+25.80%)

, MQBKY

Macquarie Group

$0.00 /

+ (+0.00%)

, WDR

Waddell & Reed

$25.44 /

+8.425 (+49.53%)

, IP

International Paper

$48.87 /

-1 (-2.01%)

, XPO

XPO Logistics

$116.19 /

+6.17 (+5.61%)

, SPLK

Splunk

$164.32 /

-41.62 (-20.21%)

, CVX

Chevron

$89.99 /

+0.12 (+0.13%)

, PDYPY

Flutter Entertainment

$0.00 /

+ (+0.00%)

The major averages remain…

ShowHide Related Items >><<
BA Boeing
$240.75 /

+16.95 (+7.57%)

CDXS Codexis
$17.17 /

-1.74 (-9.20%)

TSLA Tesla
$592.59 /

+23.905 (+4.20%)

ZS Zscaler
$184.88 /

+37.92 (+25.80%)

MQBKY Macquarie Group
$0.00 /

+ (+0.00%)

WDR Waddell & Reed
$25.44 /

+8.425 (+49.53%)

IP International Paper
$48.87 /

-1 (-2.01%)

XPO XPO Logistics
$116.19 /

+6.17 (+5.61%)

SPLK Splunk
$164.32 /

-41.62 (-20.21%)

CVX Chevron
$89.99 /

+0.12 (+0.13%)

PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

BA Boeing
$240.75 /

+16.95 (+7.57%)

12/01/20 Truist
Triumph Group upgraded to Hold from Sell at Truist
12/01/20 Truist
Spirit AeroSystems upgraded to Hold from Sell at Truist
11/30/20 Baird
Boeing checks show lack of 737 deliveries in November, says Baird
11/19/20 Susquehanna
Boeing price target raised to $275 from $220 at Susquehanna
CDXS Codexis
$17.17 /

-1.74 (-9.20%)

07/15/20 Stephens
Codexis resumed with an Overweight at Stephens
03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
TSLA Tesla
$592.59 /

+23.905 (+4.20%)

09:55 Today
Fly Intel: Top five analyst upgrades
12/02/20 Goldman Sachs
Tesla upgraded to Buy from Neutral at Goldman Sachs
11/27/20 BofA
BofA positive on long-term share gains for NIO Inc. after hosting calls
11/18/20
Fly Intel: Top five analyst upgrades
ZS Zscaler
$184.88 /

+37.92 (+25.80%)

08:54 Today Loop Capital
Zscaler price target raised to $215 from $170 at Loop Capital
08:43 Today Credit Suisse
Zscaler price target raised to $175 from $160 at Credit Suisse
08:18 Today Wedbush
Zscaler price target raised to $185 from $175 at Wedbush
08:17 Today DA Davidson
Zscaler price target raised to $185 from $155 at DA Davidson
MQBKY Macquarie Group
$0.00 /

+ (+0.00%)

11/06/20 Jefferies
Macquarie Group downgraded to Hold from Buy at Jefferies
01/28/20 Citi
Macquarie Group downgraded to Sell from Neutral at Citi
WDR Waddell & Reed
$25.44 /

+8.425 (+49.53%)

05:17 Today Evercore ISI
Waddell & Reed upgraded to In Line from Underperform at Evercore ISI
10/05/20 Jefferies
Trian involvement could by catalyst for 'beaten down' managers, says Jefferies
07/29/20 Citi
Waddell & Reed upgraded to Neutral following Q2 report at Citi
07/29/20 Citi
Waddell & Reed upgraded to Neutral from Sell at Citi
IP International Paper
$48.87 /

-1 (-2.01%)

11/16/20
Fly Intel: Top five analyst upgrades
11/16/20 Citi
International Paper upgraded to Buy from Neutral at Citi
10/11/20 BMO Capital
International Paper upgraded to Outperform from Market Perform at BMO Capital
10/09/20
Fly Intel: Top five analyst upgrades
XPO XPO Logistics
$116.19 /

+6.17 (+5.61%)

08:49 Today Stifel
XPO Logistics price target raised to $130 from $105 at Stifel
08:40 Today Loop Capital
XPO Logistics price target raised to $125 from $105 at Loop Capital
08:27 Today Wells Fargo
XPO Logistics price target raised to $158 from $111 at Wells Fargo
07:46 Today Oppenheimer
XPO Logistics price target raised to $123 from $108 at Oppenheimer
SPLK Splunk
$164.32 /

-41.62 (-20.21%)

09:55 Today
Fly Intel: Top five analyst downgrades
08:58 Today DA Davidson
Splunk downgraded to Neutral from Buy at DA Davidson
08:10 Today Morgan Stanley
Splunk price target cut to $213 at Morgan Stanley after 'negative surprise'
08:01 Today Oppenheimer
Splunk price target lowered to $203 from $250 at Oppenheimer
CVX Chevron
$89.99 /

+0.12 (+0.13%)

11/17/20
Fly Intel: Top five analyst upgrades
11/17/20 RBC Capital
Chevron upgraded to Sector Perform from Underperform at RBC Capital
11/16/20 Truist
Exxon Mobil price target raised to $39 from $36 at Truist
10/21/20 Morgan Stanley
Cimarex, Diamondback could benefit from greater scale, says Morgan Stanley
PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

11/27/20 Jefferies
Jefferies views Canada sports betting steps as positive for Flutter
11/20/20 Redburn
Flutter Entertainment downgraded to Neutral from Buy at Redburn
11/17/20 Morgan Stanley
Flutter price target raised to 13,000 GBp from 11,500 GBp at Morgan Stanley
11/12/20 Deutsche Bank
Flutter price target raised to 12,387 GBp from 11,800 GBp at Deutsche Bank
BA Boeing
$240.75 /

+16.95 (+7.57%)

CDXS Codexis
$17.17 /

-1.74 (-9.20%)

TSLA Tesla
$592.59 /

+23.905 (+4.20%)

ZS Zscaler
$184.88 /

+37.92 (+25.80%)

WDR Waddell & Reed
$25.44 /

+8.425 (+49.53%)

IP International Paper
$48.87 /

-1 (-2.01%)

XPO XPO Logistics
$116.19 /

+6.17 (+5.61%)

SPLK Splunk
$164.32 /

-41.62 (-20.21%)

CVX Chevron
$89.99 /

+0.12 (+0.13%)

  • 03
    Dec
  • 14
    Feb
BA Boeing
$240.75 /

+16.95 (+7.57%)

TSLA Tesla
$592.59 /

+23.905 (+4.20%)

ZS Zscaler
$184.88 /

+37.92 (+25.80%)

MQBKY Macquarie Group
$0.00 /

+ (+0.00%)

WDR Waddell & Reed
$25.44 /

+8.425 (+49.53%)

XPO XPO Logistics
$116.19 /

+6.17 (+5.61%)

SPLK Splunk
$164.32 /

-41.62 (-20.21%)

CVX Chevron
$89.99 /

+0.12 (+0.13%)

PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

BA Boeing
$240.75 /

+16.95 (+7.57%)

CDXS Codexis
$17.17 /

-1.74 (-9.20%)

TSLA Tesla
$592.59 /

+23.905 (+4.20%)

ZS Zscaler
$184.88 /

+37.92 (+25.80%)

WDR Waddell & Reed
$25.44 /

+8.425 (+49.53%)

IP International Paper
$48.87 /

-1 (-2.01%)

XPO XPO Logistics
$116.19 /

+6.17 (+5.61%)

SPLK Splunk
$164.32 /

-41.62 (-20.21%)

CVX Chevron
$89.99 /

+0.12 (+0.13%)

PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

BA Boeing
$240.75 /

+16.95 (+7.57%)

TSLA Tesla
$592.59 /

+23.905 (+4.20%)

ZS Zscaler
$184.88 /

+37.92 (+25.80%)

IP International Paper
$48.87 /

-1 (-2.01%)

XPO XPO Logistics
$116.19 /

+6.17 (+5.61%)

SPLK Splunk
$164.32 /

-41.62 (-20.21%)

CVX Chevron
$89.99 /

+0.12 (+0.13%)

Conference/Events
Axcelis management to meet virtually with B. Riley Securities » 12:19
12/03/20
12/03
12:19
12/03/20
12:19
ACLS

Axcelis

$28.56 /

+0.78 (+2.81%)

Virtual Meeting with a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACLS Axcelis
$28.56 /

+0.78 (+2.81%)

ACLS Axcelis
$28.56 /

+0.78 (+2.81%)

12/01/20 Stifel
Micron's Q1 preannouncement supports recent Stifel channel checks
09/20/20 Stifel
Stifel gets more positive on Semi Cap Equipment, upgrades Axcelis to Buy
09/20/20 Stifel
Axcelis upgraded to Buy from Hold at Stifel
08/12/20 Needham
Axcelis initiated with a Buy at Needham
ACLS Axcelis
$28.56 /

+0.78 (+2.81%)

Technical Analysis
NASDAQ market internals summary » 12:17
12/03/20
12/03
12:17
12/03/20
12:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Conference/Events
Altimmune management to meet virtually with B. Riley Securities » 12:16
12/03/20
12/03
12:16
12/03/20
12:16
ALT

Altimmune

$34.00 /

+16 (+4.00%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALT Altimmune
$34.00 /

+16 (+4.00%)

ALT Altimmune
$34.00 /

+16 (+4.00%)

11/25/20 Piper Sandler
Phase 1 safety/immunogenicity to set Altimmune AdCOVID apart, says Piper Sandler
11/24/20 Piper Sandler
Astra vaccine results 'de-risking' for Altimmune, says Piper Sandler
11/12/20 B. Riley Securities
Altimmune selloff on vaccine news overblown, says B. Riley Securities
10/12/20 Piper Sandler
Piper sees AdCOVID pre-clinical data helping benchmark Altimmune COVID program
  • 14
    Jul
ALT Altimmune
$34.00 /

+16 (+4.00%)

ALT Altimmune
$34.00 /

+16 (+4.00%)

Technical Analysis
NYSE market internals summary » 12:16
12/03/20
12/03
12:16
12/03/20
12:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Recommendations
G4S price target raised to 235 GBp from 210 GBp at Deutsche Bank » 12:11
12/03/20
12/03
12:11
12/03/20
12:11
GFSZY

G4S

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GFSZY G4S
$0.00 /

+ (+0.00%)

GFSZY G4S
$0.00 /

+ (+0.00%)

11/17/20 Deutsche Bank
G4S price target raised to 210 GBp from 170 GBp at Deutsche Bank
10/08/20 Kepler Cheuvreux
G4S downgraded to Hold from Buy at Kepler Cheuvreux
10/08/20 Kepler Cheuvreux
G4S downgraded to Hold from Buy at Kepler Cheuvreux
09/23/20 Morgan Stanley
G4S price target raised to 170 GBp from 155 GBp at Morgan Stanley
Recommendations
888 Holdings price target raised to 320 GBp from 290 GBp at Deutsche Bank » 12:10
12/03/20
12/03
12:10
12/03/20
12:10
EIHDF

888 Holdings

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EIHDF 888 Holdings
$0.00 /

+ (+0.00%)

10/01/20 JPMorgan
888 Holdings price target raised to 235 GBp from 200 GBp at JPMorgan
10/01/20 Deutsche Bank
888 Holdings price target raised to 290 GBp from 200 GBp at Deutsche Bank
06/29/20 Deutsche Bank
888 Holdings price target raised to 200 GBp from 188 GBp at Deutsche Bank
06/29/20 JPMorgan
888 Holdings price target raised to 200 GBp from 180 GBp at JPMorgan
Recommendations
Wacker Chemie price target raised to EUR 125 from EUR 100 at Societe Generale » 12:10
12/03/20
12/03
12:10
12/03/20
12:10
WKCMF

Wacker Chemie

$0.00 /

+ (+0.00%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WKCMF Wacker Chemie
$0.00 /

+ (+0.00%)

11/27/20 Morgan Stanley
Wacker Chemie price target raised to EUR 98 from EUR 91 at Morgan Stanley
11/24/20 Baader Helvea
Wacker Chemie upgraded to Buy from Add at Baader Helvea
11/20/20 Berenberg
Wacker Chemie price target raised to EUR 90 from EUR 80 at Berenberg
11/02/20 Morgan Stanley
Wacker Chemie price target lowered to EUR 91 from EUR 98 at Morgan Stanley
Initiation
Unilever initiated with a Buy at Societe Generale » 12:09
12/03/20
12/03
12:09
12/03/20
12:09
UN

Unilever

$60.50 /

+ (+0.00%)

, UL

Unilever

$57.86 /

-1.25 (-2.11%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UN Unilever
$60.50 /

+ (+0.00%)

UL Unilever
$57.86 /

-1.25 (-2.11%)

UN Unilever
$60.50 /

+ (+0.00%)

11/25/20 Jefferies
Jefferies sees 'strong buying opportunity' upcoming after Unilever unification
11/12/20 Citi
Unilever resumed with a Buy at Citi
10/23/20 RBC Capital
Unilever price target raised to EUR 43 from EUR 42 at RBC Capital
10/23/20 Investec
Unilever downgraded to Hold from Buy at Investec
UL Unilever
$57.86 /

-1.25 (-2.11%)

11/25/20 Jefferies
Jefferies sees 'strong buying opportunity' upcoming after Unilever unification
10/23/20 Investec
Unilever downgraded to Hold from Buy at Investec
10/19/20 Deutsche Bank
Unilever resumed with a Buy at Deutsche Bank
10/13/20 Exane BNP Paribas
Unilever upgraded to Outperform from Neutral at Exane BNP Paribas
UN Unilever
$60.50 /

+ (+0.00%)

UL Unilever
$57.86 /

-1.25 (-2.11%)

UN Unilever
$60.50 /

+ (+0.00%)

Conference/Events
SunOpta participates in a conference call with Lake Street » 12:07
12/03/20
12/03
12:07
12/03/20
12:07
STKL

SunOpta

$10.11 /

+0.07 (+0.70%)

Conference call with CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STKL SunOpta
$10.11 /

+0.07 (+0.70%)

07/22/20 Lake Street
SunOpta price target raised to $6 from $4 at Lake Street
07/22/20 DA Davidson
SunOpta initiated with a Buy at DA Davidson
STKL SunOpta
$10.11 /

+0.07 (+0.70%)

General news
Treasury's $65 B 4- and 8-week bill auctions were ok » 12:05
12/03/20
12/03
12:05
12/03/20
12:05

Treasury's $65 B 4-…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Options
Dropbox call volume above normal and directionally bullish » 12:05
12/03/20
12/03
12:05
12/03/20
12:05
DBX

Dropbox

$20.45 /

+0.34 (+1.69%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
DBX Dropbox
$20.45 /

+0.34 (+1.69%)

DBX Dropbox
$20.45 /

+0.34 (+1.69%)

11/06/20 JPMorgan
Dropbox shares look undervalued after 'good' Q3, says JPMorgan
09/29/20 Citi
Citi adds Dropbox, removes WPX from 'Value Creators' list
07/31/20
Fly Intel: Top five analyst downgrades
07/31/20 BofA
Dropbox downgraded to Neutral from Buy at BofA
DBX Dropbox
$20.45 /

+0.34 (+1.69%)

DBX Dropbox
$20.45 /

+0.34 (+1.69%)

DBX Dropbox
$20.45 /

+0.34 (+1.69%)

DBX Dropbox
$20.45 /

+0.34 (+1.69%)

Conference/Events
AutoWeb participates in a conference call with Lake Street » 12:01
12/03/20
12/03
12:01
12/03/20
12:01
AUTO

AutoWeb

$2.91 /

-0.01 (-0.34%)

Conference call with CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AUTO AutoWeb
$2.91 /

-0.01 (-0.34%)

AUTO AutoWeb
$2.91 /

-0.01 (-0.34%)

11/12/20 B. Riley Securities
AutoWeb price target lowered to $3.50 from $5 at B. Riley Securities
10/15/20 B. Riley Securities
AutoWeb price target raised to $5 from $4 at B. Riley Securities
08/27/20
Fly Intel: Top five analyst upgrades
08/27/20 Barrington
AutoWeb upgraded to Outperform from Market Perform at Barrington
AUTO AutoWeb
$2.91 /

-0.01 (-0.34%)

AUTO AutoWeb
$2.91 /

-0.01 (-0.34%)

Recommendations
LivaNova divestiture 'right choice' despite low multiple, says Piper Sandler » 11:58
12/03/20
12/03
11:58
12/03/20
11:58
LIVN

LivaNova

$55.55 /

+2.24 (+4.20%)

While the price paid for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LIVN LivaNova
$55.55 /

+2.24 (+4.20%)

LIVN LivaNova
$55.55 /

+2.24 (+4.20%)

10/29/20 Piper Sandler
LivaNova price target raised to $63 from $60 at Piper Sandler
10/21/20 Baird
LivaNova price target raised to $65 from $55 at Baird
10/12/20 Piper Sandler
LivaNova letter shows 'meaningful value remains trapped,' says Piper Sandler
09/30/20 Piper Sandler
Piper Sandler 'highly' recommends five names in Medical Technology
LIVN LivaNova
$55.55 /

+2.24 (+4.20%)

Conference/Events
Herbalife Nutrition participates in a conference call with Jefferies » 11:56
12/03/20
12/03
11:56
12/03/20
11:56
HLF

Herbalife Nutrition

$49.80 /

+1.09 (+2.24%)

Financial Analyst Barbero…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HLF Herbalife Nutrition
$49.80 /

+1.09 (+2.24%)

HLF Herbalife Nutrition
$49.80 /

+1.09 (+2.24%)

09/11/20 Jefferies
Herbalife, Nu Skin valuation gaps can close as models transform, says Jefferies
06/22/20 Citi
Citi boosts Herbalife target to $63, opens '90 Day Catalyst Watch'
05/08/20 Jefferies
Herbalife Nutrition price target raised to $45 from $40 at Jefferies
05/08/20 Citi
Herbalife Nutrition price target raised to $56 from $49 at Citi
HLF Herbalife Nutrition
$49.80 /

+1.09 (+2.24%)

HLF Herbalife Nutrition
$49.80 /

+1.09 (+2.24%)

HLF Herbalife Nutrition
$49.80 /

+1.09 (+2.24%)

HLF Herbalife Nutrition
$49.80 /

+1.09 (+2.24%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.